Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1996
12/18/1996EP0748214A1 Liposomes and use thereof especially to obtain immunomodulating compositions
12/18/1996EP0695171B1 Lyospheres comprising gonadotropin
12/18/1996EP0506914B1 Method for the diagnosis of hiv infections
12/18/1996CN1138298A Vaccines
12/18/1996CN1138295A A novel tumor suppressor gene
12/17/1996US5585499 Drug delivery
12/17/1996US5585468 Substituted thioureas as bifunctional chelators
12/17/1996US5585464 Recombinant antigen for diagnosing rheumatoid arthritis
12/17/1996US5585351 T-cadherin adhesion molecule
12/17/1996US5585344 Liver-derived receptors for advanced glycosylation endproducts and uses thereof
12/17/1996US5585268 Purified isolated dna sequence encoding specified amino acid sequence or fragment encoding polypeptide reactive with antiserum to specified plasmodium falciparum band
12/17/1996US5585264 Useful in vaccines to prevent disease in cattle
12/17/1996US5585262 Process for the production of a viable cell culture infected by a multiple sclerosis-associated virus
12/17/1996US5585250 Hiv-1 vaccine; variations and modifications of the v3 loop including additional glycosylation signals
12/17/1996US5585234 Treatment of infertile sperm in vitro with thymosin α1 to enhance penetration of mammalian ova
12/17/1996US5585233 Mutant; gebnetic engineering
12/17/1996US5585106 Nonspecific defense mechanism; administering phagocytosable particles of a particular size to enhance macrophage oxidizing activity; pretreatment for surgery, prosthetics; anticancer agents; aids
12/17/1996US5585103 Induction of cytotoxic T-lymphocyte responses
12/17/1996US5585102 Flagella-less borrelia
12/17/1996US5585100 Vaccine; diagnosis, therapy and prevention of disease
12/17/1996US5585098 Injecting fowl hen with immunogen to elicit immunoglobulin antibodies against mastitis-causing organism, administering antibodies to infected lactating ruminant
12/17/1996US5585097 Aglycosylated immunoglobulin g antibody; preventing renal allograft rejection
12/17/1996US5585096 Replication-competent herpes simplex virus mediates destruction of neoplastic cells
12/17/1996US5585089 Humanized immunoglobulins
12/17/1996CA2006684C Monoclonal antibody against protein c
12/17/1996CA1338800C Hepatitis delta and diagnostics and vaccines
12/16/1996WO1996039508A1 Fibroblast growth factor 13
12/13/1996CA2178553A1 Marek's disease vaccine
12/12/1996WO1996039629A1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
12/12/1996WO1996039541A1 Colon specific gene and protein
12/12/1996WO1996039540A1 Novel gene-up regulated in regenerating liver
12/12/1996WO1996039524A1 Methods for enhancement of protective immune responses
12/12/1996WO1996039515A1 Human vascular endothelial growth factor 2
12/12/1996WO1996039511A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR
12/12/1996WO1996039510A1 Chimeric proteins for use in transport of a selected substance into cells
12/12/1996WO1996039509A1 Fibroblast growth factor 15
12/12/1996WO1996039507A1 Fibroblast growth factor 11
12/12/1996WO1996039503A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION
12/12/1996WO1996039497A1 Transforming growth factor alpha hi
12/12/1996WO1996039491A1 Recombinant poxvirus - cytomegalovirus compositions and uses
12/12/1996WO1996039485A1 Human hepatoma-derived growth factor-2
12/12/1996WO1996039484A1 Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods
12/12/1996WO1996039442A1 G-protein receptor htnad29
12/12/1996WO1996039437A1 Human g-protein chemokine receptor hdgnr10
12/12/1996WO1996039427A1 Ligand-stimulated gene expression
12/12/1996WO1996039420A1 Human criptin growth factor
12/12/1996WO1996039419A1 Colon specific genes and proteins
12/12/1996WO1996039186A1 Anti-neutrophil cytoplasmic antibody material associated with ulcerative colitis and related methods and kits
12/12/1996WO1996039185A1 Treatment and diagnosis of prostate cancer
12/12/1996WO1996039182A1 Dual carrier immunogenic construct
12/12/1996WO1996039180A1 Immunogen preparation with hapten
12/12/1996WO1996039179A1 Novel recombinant temperature sensitive mutants of influenza
12/12/1996WO1996039178A1 A replication-defective adenovirus human type 5 recombinant as a vaccine carrier
12/12/1996WO1996039177A1 Recombinant poxvirus-calicivirus [rabbit hemorrhagic disease virus (rhdv)] compositions and uses
12/12/1996WO1996039176A1 USE OF ORAL TOLERANCE TO SUPPRESS BOTH Th1 AND Th2 IMMUNE RESPONSES AND TO SUPPRESS ANTIBODY PRODUCTION
12/12/1996WO1996039168A1 Method for increasing hdl cholesterol level
12/12/1996WO1996039113A2 Oral administration of pneumococcal antigens
12/12/1996CA2562162A1 Human g-protein chemokine receptor hdgnr10
12/12/1996CA2423891A1 Novel recombinant temperature sensitive mutants of influenza
12/12/1996CA2413012A1 Human vascular endothelial growth factor 2
12/12/1996CA2223957A1 Transforming growth factor alpha hi
12/12/1996CA2223950A1 Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods
12/12/1996CA2223733A1 Human hepatoma-derived growth factor-2
12/12/1996CA2223707A1 Novel gene-up regulated in regenerating liver
12/12/1996CA2223439A1 Anti-neutrophil cytoplasmic antibody material associated with ulcerative colitis and related methods and kits
12/12/1996CA2223421A1 Methods for enhancement of protective immune responses
12/12/1996CA2223419A1 Recombinant poxvirus-calicivirus [rabbit hemorrhagic disease virus (rhdv)] compositions and uses
12/12/1996CA2223291A1 Treatment and diagnosis of prostate cancer
12/12/1996CA2223282A1 Recombinant poxvirus - cytomegalovirus compositions and uses
12/12/1996CA2223177A1 Method for increasing hdl cholesterol level
12/12/1996CA2223038A1 A c5a-like seven transmembrane receptor
12/12/1996CA2222965A1 Oral administration of pneumococcal antigens
12/12/1996CA2222643A1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
12/12/1996CA2221798A1 Colon specific genes and proteins
12/12/1996CA2221795A1 Colon specific gene and protein
12/12/1996CA2221711A1 Chimeric proteins for use in transport of a selected substance into cells
12/12/1996CA2221706A1 G-protein receptor htnad29
12/12/1996CA2218329A1 Fibroblast growth factor-11
12/12/1996CA2217301A1 Fibroblast growth factor 15
12/12/1996CA2217216A1 Human chemokine beta-13
12/12/1996CA2196281A1 Dual carrier immunogenic construct
12/11/1996EP0747482A2 Hepatitis GB virus recombinant proteins and uses thereof
12/11/1996EP0747394A2 Hepatitis GB virus synthetic peptides and uses thereof
12/11/1996EP0747063A2 Neisseria meningitidis capsular polysaccharide conjugates
12/11/1996EP0747058A1 Acellular vaccine
12/11/1996EP0746398A1 Antibody purification
12/11/1996EP0746338A1 Vaccines containing paucilamellar lipid vesicles as immunological adjuvants
12/11/1996EP0746336A1 Prodrugs activated by targeted catalytic proteins
12/11/1996EP0746332A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof
12/11/1996EP0746329A1 Anti-inflammatory factor, method of isolation, and use
12/11/1996EP0583390B1 Detection of cardiovascular lesions
12/11/1996EP0491865B1 Conjugate vaccine for group b streptococcus
12/11/1996CN1137799A Glucosamine disaccharides, method for their preparation pharmaceutical composition comprising same and their use
12/11/1996CN1137758A Methods of prolonged suppression of humoral immunity
12/11/1996CN1137757A Compositions and methods for stimulating megakaryocyte growth and differentiation
12/10/1996US5583203 VLA proteins
12/10/1996US5583202 Antigenized antibodies and genes
12/10/1996US5583201 Using apolipoprotein e variant as marker of peripheral nerve damage
12/10/1996US5583112 Enhancing immune responses in animals
12/10/1996US5583109 Method of stimulating immune response